COMPANIES Supporting our clients’ development
Working with corporate clients of all sizes and in all business sectors, BNP Paribas provides them with a range of expert services to help them achieve their goals on the European and international markets. We take a look back at some significant initiatives and advances.
Global Banking acted as global coordinator on the initial public offering (IPO) on Euronext Paris of Exosens, the world leader in amplification, detection and imaging technologies, for approximately €400 million. Completed through a private placement with leading institutional investors, this transaction was the largest one in France this year and valued the company over a billion euros. Exosens’ flexibility was therefore increased allowing to finance both its external growth strategy and R&D investments. At the same time, this transaction provided liquidity to its main shareholder HLD, after three years of structural operational and strategic changes. For its part, BNP Paribas Leasing Solutions renewed its strategic long-term financing partnership with CNH and Iveco Group. Founded in 1997, the CNH Industrial Capital Europe joint venture now operates in nine European countries and provides leasing and financing solutions, insurance and services for CNH brand machinery and Iveco Group vehicles.
ACCOMPANYING OUR CLIENTS IN THEIR TRANSATLANTIC DEVELOPMENT
As part of our One Bank for Corporates approach, which aims to provide support for corporate clients worldwide as they expand geographically, teams from Commercial & Personal Banking in France and our Corporate & Institutional Banking division participated up to US$150 million in a US$600 million securitisation programme to support the development of Fox Rent a Car, the American subsidiary of Europcar Mobility Group, which has a network of 26 rental agencies and a fleet of 20,000 vehicles across the country. For their part, the Global Banking teams provided support for the French family-owned group Roquette, the world leader in plant-based ingredients and pharmaceutical excipients, in its acquisition of New York-based IFF Pharma Solutions. Subject to final closing, Roquette is now positioned as the global specialist in excipients for oral solutions. We worked on the financing and hedging of the transaction while acting as financial advisor to Roquette. This transaction illustrates our ability to operate in a cross-border context, on complex issues and within tight deadlines.
INVESTING TO SUPPORT TRANSITION PLAYERS
In line with our approach of gearing private equity towards a low-carbon economy and supporting sustainable energy, BNP Paribas Fortis acquired a stake in Solora, a leading player in the installation, operation and maintenance of solar facilities. In doing so, BNP Paribas Fortis is demonstrating its willingness to contribute, alongside Solora’s founding shareholders and Junction Growth Investors, to the expansion of the company’s service offering and to the completion of targeted acquisitions.
€1bn This is the market capitalisation of Exosens, following its IPO coordinated by Global Banking.